Jia Liu

机构：Qingdao University of Science and Technology, China Pharmaceutical University, Beijing University of Chinese Medicine, Peking University, Yale University, Peking University First Hospital, National Institute for Viral Disease Control and Prevention, Xi'an Jiaotong University · ORCID：0000-0002-2028-0279

发表论文 105 篇 · 总被引 1488 次 · h-index 22

代表论文

• Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 (2024 · Med · 被引 40)
• Evolution of Avian Influenza Virus (H3) with Spillover into Humans, China (2023 · Emerging infectious diseases · 被引 30)
• Sea buckthorn berries alleviate ulcerative colitis via regulating gut Faecalibaculum rodentium-mediated butyrate biosynthesis (2025 · Phytomedicine · 被引 27)
• Reported human infections of H9N2 avian influenza virus in China in 2021 (2023 · Frontiers in Public Health · 被引 26)
• Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice (2024 · Infection · 被引 23)
• Interferon regulatory factor 5: a potential target for therapeutic intervention in inflammatory diseases (2025 · Frontiers in Immunology · 被引 16)